Therapy with belimumab may suppress the response of peripheral blood mononuclear cells to apoptotic cells
Belimumab, on top of background Systemic Lupus Erythematosus (SLE) standard therapy, is effective in reducing SLE disease activity and preventing lupus flares, which was confirmed in “BLISS trials”. The mechanisms…

